1.69 USD
↘ 0.33 (16.10%)AT CLOSE (11:59 AM EDT)
Palisade Bio, Inc. Common Stock
PALINASDAQ • USD
1.74
↗ 0.05 (3.08%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
1.74
↗ 0.05 (3.08%)
Market: CLOSED
Palisade Bio, Inc. Common Stock (PALI) trades at $1.68 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. PALI is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Sep 16, 2026.
Open?$2.04
High?$2.04
Low?$1.67
Prev. Close?$2.02
Volume?8.4M
Avg. Volume?2.0M
VWAP?$1.83
Rel. Volume?4.13x
Bid / Ask
Bid?$1.73 × 6.6K
Ask?$1.75 × 300
Spread?$0.02
Midpoint?$1.74
Valuation & Ratios
Market Cap?294.5M
Shares Out?174.3M
Float?165.0M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.42
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
351.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?36.28Safe
Confidence?48%Low
Short InterestVery High
Short % of Float?18.73%High
Short Interest?30.9M
Days to Cover?19.1
Free Float165.0M
Avg Daily Volume1.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?24.26Strong
Quick Ratio?24.26Strong
Cash Ratio?23.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.42CHEAP▾
Peers100
S&P66
P/S?589.03HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.8CHEAP▾
S&P97
EV/Sales?338.69HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-26.2%WEAK▾
S&P7
ROA?-25.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-18190000
Enterprise Value?$169.3M
Fundamentals ratios updated end of day